Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis
Circulation · 21.02.2023 · 147 (8) · 669-685
DOI: 10.1161/circulationaha.122.063075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 21.02.2023. Verfasst von Yunzhou Dong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Program (Y.D., B.W., B.Z., K. Cui, K.L., D.B.C., S.B., S.W., J.B., H.C.), Boston Children's Hospital, MA. Hauptthemen laut MEDLINE: Transforming Growth Factor beta, Atherosclerosis. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Background
Epsin endocytic adaptor proteins are implicated in the progression of atherosclerosis; however, the underlying molecular mechanisms have not yet been fully defined. In this study, we determined how epsins enhance endothelial-to-mesenchymal transition (EndoMT) in atherosclerosis and assessed the efficacy of a therapeutic peptide in a preclinical model of this disease.
Methods
Using single-cell RNA sequencing combined with molecular, cellular, and biochemical analyses, we investigated the role of epsins in stimulating EndoMT using knockout in Apoe −/− and lineage tracing/proprotein convertase subtilisin/kexin type 9 serine protease mutant viral-induced atherosclerotic mouse models. The therapeutic efficacy of a synthetic peptide targeting atherosclerotic plaques was then assessed in Apoe −/− mice.
Results
Single-cell RNA sequencing and lineage tracing revealed that epsins 1 and 2 promote EndoMT and that the loss of endothelial epsins inhibits EndoMT marker expression and transforming growth factor-β signaling in vitro and in atherosclerotic mice, which is associated with smaller lesions in the Apoe −/− mouse model. Mechanistically, the loss of endothelial cell epsins results in increased fibroblast growth factor receptor-1 expression, which inhibits transforming growth factor-β signaling and EndoMT. Epsins directly bind ubiquitinated fibroblast growth factor receptor-1 through their ubiquitin-interacting motif, which results in endocytosis and degradation of this receptor complex. Consequently, administration of a synthetic ubiquitin-interacting motif–containing peptide atheroma ubiquitin-interacting motif peptide inhibitor significantly attenuates EndoMT and progression of atherosclerosis.
Conclusions
We conclude that epsins potentiate EndoMT during atherogenesis by increasing transforming growth factor-β signaling through fibroblast growth factor receptor-1 internalization and degradation. Inhibition of EndoMT by reducing epsin–fibroblast growth factor receptor-1 interaction with a therapeutic peptide may represent a novel treatment strategy for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Biology Program (Y.D., B.W., B.Z., K. Cui, K.L., D.B.C., S.B., S.W., J.B., H.C.), Boston Children's Hospital, MA.
- Departments of Surgery (Y.D., B.W., B.Z., K. Cui, D.B.C., S.B., J.B., H.C.), Harvard Medical School, Boston, MA.
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA (M.D.).
- Department of Medicine (K.Y.), Boston Children's Hospital, MA.
- Pediatrics (K.Y., K. Chen), Harvard Medical School, Boston, MA.
- Department of Anesthesia (J.S.), Harvard Medical School, Boston, MA.
ORCID-Profile: Kui Cui, Douglas B Cowan, Jinjun Shi, Kaifu Chen, Joyce Bischoff, MacRae F Linton, Hong Chen
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- BLRD VA
Zitieren
APA
Dong, Y., Wang, B., Du, M., Zhu, B., Cui, K., Li, K., Yuan, K., Cowan, D. B., Bhattacharjee, S., Wong, S., Shi, J., Wang, D. Z., Chen, K., Bischoff, J., Linton, M. F., & Chen, H. (2023). Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis. Circulation, 147(8), 669-685. https://doi.org/10.1161/circulationaha.122.063075
Vancouver
Dong Y, Wang B, Du M, Zhu B, Cui K, Li K, et al. Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis. Circulation. 2023;147(8):669-685. doi:10.1161/circulationaha.122.063075
BibTeX
@article{Dong2023,
author = {Dong, Yunzhou and Wang, Beibei and Du, Mulong and Zhu, Bo and Cui, Kui and Li, Kathryn and Yuan, Ke and Cowan, Douglas B and Bhattacharjee, Sudarshan and Wong, Scott and Shi, Jinjun and Wang, Da-Zhi and Chen, Kaifu and Bischoff, Joyce and Linton, MacRae F and Chen, Hong},
title = {Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis},
journal = {Circulation},
year = {2023},
volume = {147},
number = {8},
pages = {669--685},
doi = {10.1161/circulationaha.122.063075}
}
EUVIMED